Korean SMEs Join Global R&D Partnerships With Fraunhofer, TNO, CSEM and North American Institutions

Define the Research Gap with Precision

Korean SMEs on the programme knew exactly what they needed: a research partner with frontier capability in a specific technology area (electronics, materials, microtechnology) and a route to technology transfer and overseas commercialisation. They didn’t need to build a research laboratory, they needed access to one. Define your gap that precisely. Vague needs produce vague partner searches and failed collaborations. Start with global market research for manufacturers to identify where your technology roadmap and research capability intersect.

Find Verified R&D Partners, Not Just Any Institution

The crucial word is “verified.” Fraunhofer, TNO, and CSEM are not random research organisations, they are established institutions with proven industry collaboration and technology transfer track records. For businesses that don’t have an existing research network, GTsetu provides verified profiles of research institutions, technology integrators, and R&D service providers across South Korea, Europe, North America, and 100+ countries. GTsetu verifies companies using government tie-ups on 6 key points: Name, Address, Registration Number, Company Status, Company Type, and Date of Certificate of Incorporation. Additional information like research expertise and co-development track record is self-reported and should be validated through commercial due diligence.

Protect Your IP and Technology Before Any Disclosure

In R&D co-development partnerships, your technology roadmap, invention disclosures, and commercial strategy are valuable IP. Before sharing anything sensitive, execute a mutual NDA. This is non-negotiable regardless of how well you think you know the research institution. GTsetu’s built-in NDA workflow handles this automatically: mutual NDA executed and countersigned before any sensitive information is shared, with a full digital audit trail. For the IP framework, see asset purchase agreement and warranty clause for the commercial terms.

Choose the Right Collaboration Structure for Your Objective

The Korean SME global R&D programme chose an R&D and co-development partnership model with technology transfer support. This is right when you need frontier research capability and shared IP. A technology licensing arrangement is right when you need faster access to existing technology. A research consortium is right for large, multi-party programmes. Contract research is right for specific testing or validation work. Match the structure to the objective, not to what’s easiest to negotiate. For certification groundwork, see manufacturing certifications for international trade.

Formalise and Commercialise in Stages, IP First, Scale Second

The Korean SME global R&D programme structured IP and technology transfer terms first, and the overseas commercialisation followed, in that order. The co-development agreement unlocks the partnership opportunity; the technology transfer and commercialisation capitalise on it. Never commit to full-scale R&D investment before you have the IP framework and technology transfer terms in place. Structure every collaboration milestone formally in writing: research scope, IP ownership, licensing terms, commercialisation rights, and performance metrics. For risk allocation, see risk allocation in cross-border deals and material breach.

“An R&D partnership is just a research grant, the real work will happen without the formal agreement.”

The Korean SME global R&D programme structured IP ownership, technology transfer terms, and commercialisation rights before any research began. The co-development agreement is the foundation for all subsequent work. Without it, there is no clarity on IP ownership, no licensing terms, and no commercialisation pathway. The agreement is not the end of the work, it’s the beginning of the research and commercialisation programme.

“The research institution’s IP automatically becomes our IP.”

A co-development partnership with Fraunhofer, TNO, or CSEM gives you access to research capability and a route to technology transfer, not automatic ownership of the institution’s background IP. IP ownership must be explicitly negotiated: background IP, foreground IP, field-of-use, licensing terms, and commercialisation rights. The research institution’s IP is a door-opener, not a guarantee. Plan the IP and licensing framework separately from the research agreement.

“We should build our own research capability to maintain control.”

Korean SMEs on the programme did the opposite, they leveraged research institutions’ existing capability instead of building it in-house. Building a world-class research laboratory would take years and require resources no SME has. The partnership model provides immediate access to frontier research. The correct sequence is: partnership → co-development → commercialisation. Never build research infrastructure before you have validated the technology through a research partnership.

“An international R&D partnership requires permanent co-location to manage effectively.”

The Korean SME global R&D partnerships are managed through structured governance mechanisms and scheduled review sessions rather than permanent co-location. What matters is clear protocols for research milestones, IP disclosure, and commercialisation decisions, not permanent proximity. GTsetu’s encrypted collaboration workspace supports exactly this structured working relationship.

“We can figure out the IP ownership and licensing terms after the research starts.”

IP disputes are the most common reason R&D partnerships collapse, and they are almost always caused by vague or absent upfront agreements. Once research results exist on undefined IP terms, both parties’ leverage is gone. In R&D co-development partnerships, technology roadmaps and invention disclosures are critical assets. Define IP ownership, licensing terms, field-of-use, and commercialisation rights before the first research milestone is agreed. For the wider contractual framework, see master services agreement and termination for convenience.